http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114518456-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0729b244445c470818ee3f4d96f79b1b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f30a90d56a22dd6da3516e4707ef89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80cd00e3836b9377d2f260cf980ca21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9bba4c1c93ada7969cecffbaea7da6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a9854d10e3837415fa464a06b38b6b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e845fdf1eca47d0908be1adb7129896 |
| publicationDate | 2022-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114518456-A |
| titleOfInvention | A method and kit for predicting the efficacy of tumor immunotherapy by DIAPH1 protein |
| abstract | The invention provides a method and kit for predicting the efficacy of tumor immunotherapy by using DIAPH1 protein. The method includes the following steps: using DIAPH1 protein as a molecular marker, using DIAPH1 monoclonal antibody or polyclonal antibody, combined with immunohistochemical reagents, and detecting The expression level of DIAPH1 protein in tumor tissue, and the efficacy of immunotherapy for patients is predicted according to the expression level of DIAPH1 protein in tumor tissue. The present invention uses DIAPH1 protein as a protein molecular marker for judging the efficacy of immunotherapy in patients. Compared with PD-L1 expression, DIAPH1 expression has a more significant predictive value for immunotherapy, and has important guiding significance for whether a patient is suitable for immunotherapy treatment. |
| priorityDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.